601 related articles for article (PubMed ID: 32004747)
1. Current and Future Treatments of Rhinitis and Sinusitis.
Patel GB; Kern RC; Bernstein JA; Hae-Sim P; Peters AT
J Allergy Clin Immunol Pract; 2020 May; 8(5):1522-1531. PubMed ID: 32004747
[TBL] [Abstract][Full Text] [Related]
2. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
[TBL] [Abstract][Full Text] [Related]
3. What is the evidence for fluticasone exhalation delivery system in chronic rhinosinusitis?
Kovacs AJ; Goshtasbi K; Kuan EC
Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):14-17. PubMed ID: 31789927
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND
Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).
Palmer JN; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Messina J; Ow RA; Patel ZM; Peters AT; Sacks H; Schlosser RJ; Sindwani R; Soler ZM; White AA; Wise SK; Mahmoud RA
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1049-1061. PubMed ID: 38244014
[TBL] [Abstract][Full Text] [Related]
6. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.
Leopold DA; Elkayam D; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
J Allergy Clin Immunol; 2019 Jan; 143(1):126-134.e5. PubMed ID: 29928924
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery.
Ow RA; Soler ZM; Sindwani R; Leopold DA; Lee JT; Mahmoud RA; Han JK
Int Forum Allergy Rhinol; 2023 Jan; 13(1):31-41. PubMed ID: 35674488
[TBL] [Abstract][Full Text] [Related]
8. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
[TBL] [Abstract][Full Text] [Related]
9. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
10. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
11. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
Clottu A; Reinhard A; Comte D
Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
[TBL] [Abstract][Full Text] [Related]
12. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
13. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
14. Exhalation Delivery Systems for Application of Intranasal Corticosteroids.
Kovacs AJ; Adappa ND; Kuan EC
Ear Nose Throat J; 2021 Jun; 100(5):309-313. PubMed ID: 33305974
[TBL] [Abstract][Full Text] [Related]
15. EDS-FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps.
Leopold DA; Elkayam D; Han JK; Soteres DF; Messina JC; Carothers JL; Sacks HJ; Mahmoud RA; Djupesland PG; Sindwani R
Int Forum Allergy Rhinol; 2022 Jun; 12(6):893-895. PubMed ID: 35348302
[No Abstract] [Full Text] [Related]
16. Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives.
Li T; Yin J; Yang Y; Wang G; Zhang Y; Song X
Expert Rev Clin Immunol; 2023; 19(8):939-948. PubMed ID: 37378551
[TBL] [Abstract][Full Text] [Related]
17. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M
Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for chronic rhinosinusitis with nasal polyps.
Wallace DV
Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152
[No Abstract] [Full Text] [Related]
19. Real-Life Experience of Monoclonal Antibody Treatments in Chronic Rhinosinusitis with Nasal Polyposis.
Meier EC; Schmid-Grendelmeier P; Steiner UC; Soyka MB
Int Arch Allergy Immunol; 2021; 182(8):736-743. PubMed ID: 33756474
[TBL] [Abstract][Full Text] [Related]
20. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.
Sher MR; Steven GC; Romett JL; Pien G; LeBenger K; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
Rhinology; 2020 Feb; 58(1):25-35. PubMed ID: 31815255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
